Samuel R Chamberlain1, Jon E Grant2. 1. 1Department of Psychiatry,University of Cambridge,and Cambridge and Peterborough NHS Foundation Trust,Cambridge,UK. 2. 2Department of Psychiatry & Behavioral Neuroscience,University of Chicago,Chicago,IL,USA.
Abstract
OBJECTIVE: Compulsivity refers to a tendency toward repetitive habitual behaviors. Multiple disorders have compulsive symptoms at their core, including substance use disorders, gambling disorder, and obsessive-compulsive disorder. The aim of this study was to validate a scale for the objective, transdiagnostic measurement of compulsivity. METHODS: The 15-item Cambridge-Chicago Compulsivity Trait Scale (CHI-T) was developed for the rapid but comprehensive measurement of compulsivity. Adults aged 18-29y were recruited using media advertisements, and completed the CHI-T in addition to demographic, clinical, and cognitive assessment. The validity and psychometric properties of the scale were quantified. RESULTS: A total of 112 participants completed the study. The scale yielded a normal distribution with very few outliers. It had excellent psychometric properties, with high internal consistency (Cronbach's alpha=0.8), and excellent convergent validity against gold-standard assessments of compulsive symptoms (each p<0.001 for gambling disorder, obsessive-compulsive, and substance use disorder symptoms). Total scores on the scale correlated significantly with less risk-adjustment on the decision-making task (rigid response style), and divergent validity was confirmed against other cognitive domains (response inhibition and executive planning). The above significant findings withstood Bonferroni correction. Factor analysis suggested the existence of two latent factors: one related mainly to reward-seeking and the need for perfection, and the other relating to anxiolytic/soothing features of compulsivity. CONCLUSION: The CHI-T, a scale designed to measure transdiagnostic compulsivity, appears to show excellent psychometric properties in a normative population and merits further investigation in the context of clinical patient populations, including in treatment trials.
OBJECTIVE: Compulsivity refers to a tendency toward repetitive habitual behaviors. Multiple disorders have compulsive symptoms at their core, including substance use disorders, gambling disorder, and obsessive-compulsive disorder. The aim of this study was to validate a scale for the objective, transdiagnostic measurement of compulsivity. METHODS: The 15-item Cambridge-Chicago Compulsivity Trait Scale (CHI-T) was developed for the rapid but comprehensive measurement of compulsivity. Adults aged 18-29y were recruited using media advertisements, and completed the CHI-T in addition to demographic, clinical, and cognitive assessment. The validity and psychometric properties of the scale were quantified. RESULTS: A total of 112 participants completed the study. The scale yielded a normal distribution with very few outliers. It had excellent psychometric properties, with high internal consistency (Cronbach's alpha=0.8), and excellent convergent validity against gold-standard assessments of compulsive symptoms (each p<0.001 for gambling disorder, obsessive-compulsive, and substance use disorder symptoms). Total scores on the scale correlated significantly with less risk-adjustment on the decision-making task (rigid response style), and divergent validity was confirmed against other cognitive domains (response inhibition and executive planning). The above significant findings withstood Bonferroni correction. Factor analysis suggested the existence of two latent factors: one related mainly to reward-seeking and the need for perfection, and the other relating to anxiolytic/soothing features of compulsivity. CONCLUSION: The CHI-T, a scale designed to measure transdiagnostic compulsivity, appears to show excellent psychometric properties in a normative population and merits further investigation in the context of clinicalpatient populations, including in treatment trials.
Entities:
Keywords:
Compulsivity; OCD; RDoc; gambling; rigid; substance use
Authors: Jon E Grant; Marvin A Steinberg; Suck Won Kim; Bruce J Rounsaville; Marc N Potenza Journal: Psychiatry Res Date: 2004-08-30 Impact factor: 3.222
Authors: Lucy Albertella; Mike E Le Pelley; Samuel R Chamberlain; Fred Westbrook; Rico S C Lee; Leonardo F Fontenelle; Jon E Grant; Rebecca A Segrave; Eugene McTavish; Murat Yücel Journal: J Behav Ther Exp Psychiatry Date: 2020-05-01
Authors: Jon E Grant; Katherine Lust; Daniel J Fridberg; Andrea C King; Samuel R Chamberlain Journal: Ann Clin Psychiatry Date: 2019-02 Impact factor: 1.567
Authors: Christine Lochner; Lucy Albertella; Martin Kidd; Zelal Kilic; Konstantinos Ioannidis; Jon E Grant; Murat Yücel; Dan J Stein; Samuel R Chamberlain Journal: J Psychiatr Res Date: 2022-06-28 Impact factor: 5.250
Authors: Roxanne W Hook; Jon E Grant; Konstantinos Ioannidis; Jeggan Tiego; Murat Yücel; Paul Wilkinson; Samuel R Chamberlain Journal: Neurosci Biobehav Rev Date: 2020-10-25 Impact factor: 8.989
Authors: Lucy Albertella; Kristian Rotaru; Erynn Christensen; Amelia Lowe; Mary-Ellen Brierley; Karyn Richardson; Samuel R Chamberlain; Rico S C Lee; Edouard Kayayan; Jon E Grant; Sam Schluter-Hughes; Campbell Ince; Leonardo F Fontenelle; Rebecca Segrave; Murat Yücel Journal: Front Psychiatry Date: 2021-02-23 Impact factor: 4.157
Authors: N A Fineberg; Z Demetrovics; D J Stein; K Ioannidis; M N Potenza; E Grünblatt; M Brand; J Billieux; L Carmi; D L King; J E Grant; M Yücel; B Dell'Osso; H J Rumpf; N Hall; E Hollander; A Goudriaan; J Menchon; J Zohar; J Burkauskas; G Martinotti; M Van Ameringen; O Corazza; S Pallanti; S R Chamberlain Journal: Eur Neuropsychopharmacol Date: 2018-10-10 Impact factor: 4.600
Authors: Adam Hampshire; Peter J Hellyer; Eyal Soreq; Mitul A Mehta; Konstantinos Ioannidis; William Trender; Jon E Grant; Samuel R Chamberlain Journal: Nat Commun Date: 2021-07-16 Impact factor: 14.919